Coprogen B from

Bishant Pokharel, Wachiraporn Tipsuwan, Monsicha Pongpom, Teera Chewonarin, Pimpisid Koonyosying, Agostino Cilibrizzi, Somdet Srichairatanakool

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bishant PokharelDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0009-0008-6638-113X

Wachiraporn TipsuwanDivision of Biochemistry, School of Medical Science, University of Phayao, Phayao 56000, Thailand.

Monsicha PongpomDepartment of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-4822-5850

Teera ChewonarinDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-9044-3777

Pimpisid KoonyosyingDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-6119-7009

Agostino CilibrizziInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.ORCID 0000-0002-9711-5183

Somdet SrichairatanakoolDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-5706-8781

Funding

Chiang Mai University Grant, Thailand TG2566P010/2567Distinguished Professor Somdet Srichairatanakool Grant, National Research Council of Thailand, Thailand N42A670732NFaculty of Medicine Fund, Chiang Mai University, Thailand BIO-2566-0574Presidential Ph.D. Scholarship, Chiang Mai University, Thailand 2563-009

6 · The paper itself

Abstract

Iron (Fe) chelators are used to treat iron-overloaded disorders, metal detoxification, radionuclides, and molecular imaging; however, they can cause side effects. In this study, we identified and characterized Coprogen B (CPGB), a hexadentate trihydroxamate siderophore secreted by the opportunistic dimorphic fungus

Indexed as

DeferoxamineIronIron Chelating AgentsSiderophoresTalaromycesChromatography, High Pressure LiquidHydroxamic AcidscoprogenDeferoxamineHydroxamic AcidsIronIron Chelating AgentsSiderophoreschelatorcLogPcoprogenironpartitionsiderophoretalaromyces

Identifiers

PMID41373444

DOI10.3390/ijms262311281

PMCPMC12692349

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.